Page last updated: 2024-10-28

hydroxyurea and Cytomegalovirus Infections

hydroxyurea has been researched along with Cytomegalovirus Infections in 6 studies

Cytomegalovirus Infections: Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults.

Research Excerpts

ExcerptRelevanceReference
"Ganciclovir (GCV) is a deoxyguanosine analog that is effective in inhibiting human cytomegalovirus (HCMV) replication."7.79Ribonucleotide reductase inhibitors hydroxyurea, didox, and trimidox inhibit human cytomegalovirus replication in vitro and synergize with ganciclovir. ( Bhave, S; Elford, H; McVoy, MA, 2013)
"Ganciclovir (GCV) is a deoxyguanosine analog that is effective in inhibiting human cytomegalovirus (HCMV) replication."3.79Ribonucleotide reductase inhibitors hydroxyurea, didox, and trimidox inhibit human cytomegalovirus replication in vitro and synergize with ganciclovir. ( Bhave, S; Elford, H; McVoy, MA, 2013)
"In conclusion, patients with acute myeloid leukemia receiving chemotherapy should be monitored for active CMV infection."1.36Prospective cytomegalovirus monitoring during first-line chemotherapy in patients with acute myeloid leukemia. ( Capobianchi, A; Capria, S; Cardarelli, L; Foà, R; Gentile, G; Gianfelici, V; Martino, P; Meloni, G; Trisolini, SM, 2010)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's2 (33.33)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bhave, S1
Elford, H1
McVoy, MA1
Capria, S1
Gentile, G1
Capobianchi, A1
Cardarelli, L1
Gianfelici, V1
Trisolini, SM1
Foà, R1
Martino, P1
Meloni, G1
Gardner, L1
Grosso, LE1
Mascolini, M1
Hambach, L1
Eder, M1
Dammann, E1
Battmer, K1
Stucki, A1
Heil, G1
Ganser, A1
Hertenstein, B1
Arnulf, B1
Chebbi, F1
Lefrere, F1
Ait Arkoub, Z1
Varet, B1
Fillet, AM1

Reviews

1 review available for hydroxyurea and Cytomegalovirus Infections

ArticleYear
Donor cell-derived acute myeloid leukemia developing 14 months after matched unrelated bone marrow transplantation for chronic myeloid leukemia.
    Bone marrow transplantation, 2001, Volume: 28, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bone Marrow Transplantation

2001

Other Studies

5 other studies available for hydroxyurea and Cytomegalovirus Infections

ArticleYear
Ribonucleotide reductase inhibitors hydroxyurea, didox, and trimidox inhibit human cytomegalovirus replication in vitro and synergize with ganciclovir.
    Antiviral research, 2013, Volume: 100, Issue:1

    Topics: Antiviral Agents; Benzamidines; Cell Line; Cytomegalovirus; Cytomegalovirus Infections; Drug Synergi

2013
Prospective cytomegalovirus monitoring during first-line chemotherapy in patients with acute myeloid leukemia.
    Journal of medical virology, 2010, Volume: 82, Issue:7

    Topics: Adult; Antibiotics, Antineoplastic; Antibodies, Viral; Antigens, Viral; Antineoplastic Agents; Antiv

2010
Gancyclovir-induced megakaryocyte loss in chronic myelogenous leukemia post bone-marrow transplant.
    American journal of hematology, 1996, Volume: 53, Issue:3

    Topics: Adult; Antineoplastic Agents, Alkylating; Antiviral Agents; Bone Marrow; Bone Marrow Transplantation

1996
ICAAC and Hamburg: Part 3. Fruhlingstraum, or what it takes to mend an immune system.
    Journal of the International Association of Physicians in AIDS Care, 1998, Volume: 4, Issue:1

    Topics: Adjuvants, Immunologic; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Biomarkers; CD4 Lymp

1998
Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
    Bone marrow transplantation, 2001, Volume: 28, Issue:8

    Topics: Acyclovir; Antineoplastic Agents, Alkylating; Antiviral Agents; Bone Marrow Transplantation; Cidofov

2001